Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea
Sohn, Y.M.; Lee, J.S.; Park, J.H.; Poerschke, G.; Eves, K.; Gress, J.; Kuter, B.
Southeast Asian Journal of Tropical Medicine and Public Health 35(4): 954-958
2004
ISSN/ISBN: 0125-1562 PMID: 15916097 Document Number: 569986
We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.